Website last accessed on 04.06.2023
Youtube Video
How do vaccines work to protect us? What are the vaccine technologies in the pipeline and how do we ensure safe vaccines? Dr Katherine O’ Brien explains in Science in 5 !
Data ultima verifica: 23 marzo 2020
Guide de référence rapide à l’intention des autorités sanitaires et des soignants
Révisé en 2015
BMC Res Notes (2016) 9:182 DOI 10.1186/s13104-016-1993-7
If you are fully vaccinated can you still get COVID-19? How frequent are breakthrough infections and what does COVID-19 look like if you are fully vaccinated. WHO’s Dr Kate O’Brien explains in Science in 5.
No matter whether you are vaccinated against #COVID19 or are still waiting, keep followi...ng these precautions to protect yourself and others:
- Avoid crowds
- Keep physical distance
- Open windows
more
De esta manera se presenta junto al equipo de trabajo estos ejemplares que abarcan
las priorizaciones de la vigilancia epidemiológica y condensan el conocimiento y el
esfuerzo de un grupo multidisciplinario de profesionales, del Ministerio de Salud Pública y
Asistencia Social, para responder a ...los cambios de tendencias epidemiológicas y con ello
contribuir al fortalecimiento de prácticas asertivas de la salud pública de nuestro país.
more
Which communities are most at risk of Monkeypox in the current outbreak and why? WHO’s Andy Seale explains how we can support the communities at risk in Science in 5.
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
The global prevalence, morbidity and mortality related to childhood asthma among children has increased significantly over the last 40 years. Although asthma is recognized as the most common chronic disease in children, issues of underdiagnosis and undertreatment persist. There are substantial globa...l variations in the prevalence of asthma symptoms in children, with up to 13-fold differences between countries. The rising number of hospital admissions for asthma may reflect an increase in asthma severity, poor disease management and/or the effect of poverty. The financial burden of asthma is relatively high within developed countries (those for which data is available) spending 1 to 2% of their healthcare budget on this condition. Established in 1989, the Global Initiative for Asthma (GINA) attempts to raise awareness about the increasing prevalence of asthma, improve management and reduce the burden of asthma worldwide. Despite global efforts, GINA has not achieved its goal, even among developed nations. There are multiple barriers to reducing the global burden of asthma, including limited access to care and/or medications, and lack of prioritization as a public healthcare priority. In addition, the diversity of healthcare systems worldwide and large differences in access to care require that asthma management guidelines be tailored to local needs.
more
doi: 10.7861/clinmedicine.15-1-54
Clin Med February 1, 2015 vol. 15 no. 1 54-57
The threat posed by Zika virus infection highlights the need to reinforce preparedness arrangements for mosquito-borne diseases in EU/EEA countries, especially for pathogens transmitted by Aedes aegypti and Aedes albopictus.
The aim of this document is to highlight measures that can effectively red...uce the risk of importation and local transmission of pathogens transmitted by Ae. aegypti and Ae. albopictus. The main diseases of concern in this context are Zika, dengue, chikungunya and yellow fever.
more
Dieser E-Learning-Kurs verschafft Ihnen durch informative Texte, anschauliche Fallbeispiele und nützliche Links einen umfassenden Überblick zur Diabetes-Situation weltweit. Der Schwerpunkt liegt dabei auf dem globalen Süden. Praktische Hilfestellungen für Ihre Arbeit runden das Angebot ab. Für ...die Bearbeitung der gesamten E-Learning Einheit benötigen Sie etwa zweieinhalb Stunden.
Modul A: Überblick zur aktuellen Situation; Folgen für Länder des globalen Südens (Daür: ca. 15 Min.);
Modul B: Medizinische Grundlagen; Ursachen und Komplikationen; Zusammenhänge mit nfektionskrankheiten (Daür: ca. 30 Min.); Modul C: Grundlagen von Diagnose, Behandlung und Schulung; Präventionsmaßnahmen; Probleme beim Zugang zu Medikamenten (Daür: ca. 30 Min.); Modul D: Nutzen und Schaden gängiger Antidiabetika, rationale Auswahl von Medikamenten (Daür: ca. 30 Min.); Modul E: Globale Verbreitung von Diabetes; Länderstudien; politischen Gegenmaßnahmen und WHO-Pläne (Daür: ca. 30 Min.); Modul F: Praktische Hilfestellungen für die Arbeit (Daür: ca. 15 Min.)
more